Literature DB >> 7847909

[Liver pathology within the scope of HELLP syndrome].

H Schneider1.   

Abstract

Liver pathology is one of the main features of HELLP syndrome and develops on the basis of a generalised activation of intravascular coagulation. Fibrin deposits and haemorrhagic necrosis predominantly develop in the periportal areas and may eventually lead to subcapsular haematomas or even rupture of the liver. While the compensated form of activation of intravascular coagulation, which is diagnosed by a decrease in antithrombin III and an increase in thrombin-antithrombin III complex (TAT) and the appearance of fibrin, monomers and D-dimers, is found in almost all cases of HELLP syndrome, the decompensated form of intravascular coagulation with prolonged bleeding time (PT, PTT) and drop in fibrinogen is found only in the most severe forms. The development of a decompensation of coagulation correlates with the appearance of severe complications such as liver haematoma, abruptio placentae, renal failure and pulmonary oedema. The best prophylaxis against the development of life-threatening complications is early diagnosis and termination of pregnancy after stabilisation of the maternal condition, consisting of magnesium sulphate infusion, antihypertensive treatment with dihydralazine or calcium antagonists, steroids etc. Severe complications of HELLP syndrome have occasionally been observed in the postpartum period. As prophylaxis against postpartal worsening of HELLP syndrome, curettage of the uterus and continuation of the treatment with calcium antagonists and dexamethasone have been recommended.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847909     DOI: 10.1007/bf02389238

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  30 in total

Review 1.  Liver diseases unique to pregnancy.

Authors:  B Schorr-Lesnick; E Lebovics; B Dworkin; W S Rosenthal
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

2.  Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia.

Authors:  P A Van Dam; M Renier; M Baekelandt; P Buytaert; F Uyttenbroeck
Journal:  Obstet Gynecol       Date:  1989-01       Impact factor: 7.661

3.  Severe pre-eclampsia: another great imitator.

Authors:  R C Goodlin
Journal:  Am J Obstet Gynecol       Date:  1976-07-15       Impact factor: 8.661

4.  Sonographic findings in severe preeclampsia twenty-four hours prior to clinical signs.

Authors:  B R Benacerraf; F D Frigoletto; C A Martini
Journal:  Am J Obstet Gynecol       Date:  1985-07-15       Impact factor: 8.661

5.  Severe preeclampsia with persistent postpartum hemolysis and thrombocytopenia treated by plasmapheresis.

Authors:  M L Schwartz; W Brenner
Journal:  Obstet Gynecol       Date:  1985-03       Impact factor: 7.661

6.  Pre-eclampsia: more than pregnancy-induced hypertension.

Authors:  J M Roberts; C W Redman
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

7.  Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

Authors:  B M Sibai; M K Ramadan; I Usta; M Salama; B M Mercer; S A Friedman
Journal:  Am J Obstet Gynecol       Date:  1993-10       Impact factor: 8.661

8.  Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases.

Authors:  D B Rolfes; K G Ishak
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

9.  Hemolysis in hypertensive disorders of pregnancy.

Authors:  H Schröcksnadel; B Sitte; G Steckel-Berger; O Dapunt
Journal:  Gynecol Obstet Invest       Date:  1992       Impact factor: 2.031

10.  Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy.

Authors:  L Weinstein
Journal:  Am J Obstet Gynecol       Date:  1982-01-15       Impact factor: 8.661

View more
  3 in total

Review 1.  HELLP syndrome as a cause of unexpected rapid maternal death--a case report and review of the literature.

Authors:  M Simic; M Tasic; G Stojiljkovic; D Draskovic; R Vukovic
Journal:  Int J Legal Med       Date:  2004-11-11       Impact factor: 2.686

2.  Maternal and pregnancy-related death: causes and frequencies in an autopsy study population.

Authors:  Claas Buschmann; Martina Schmidbauer; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2012-12-29       Impact factor: 2.007

Review 3.  Pathological AT1R-B2R Protein Aggregation and Preeclampsia.

Authors:  Ursula Quitterer; Said AbdAlla
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.